IRIngersoll Rand
Ingersoll Rand Inc. is a diversified, global provider of mission-critical flow creation products, and industrial and life science solutions. 10-K, Item 1
- Employees
- 21,000
- Headquarters
- Davidson, NC
- Next results
- around Feb 11, 2027
What IR's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Vicente Reynal Chairman, President and Chief Executive Officer |
Adopted 10b5-1 plan | May 22, 2025 | up to 496,746 | May 11, 2026 | 10-Q Jul 31, 2025 |
| Vicente Reynal Chairman, President and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 3, 2024 | up to 456,974 | 1 days | 10-Q May 3, 2024 |
The company's descriptionOn March 3, 2024, Vicente Reynal, the Company's Chairman, President and Chief Executive Officer, adopted a 10b5-1 trading arrangement (a “10b5-1 Plan”). Mr. Reynal’s 10b5-1 Plan provides for the potential sale of up to 456,974 shares of the Company’s common stock, obtained from the exercise of vested stock options covered by the 10b5-1 Plan, from June 3, 2024 through June 4, 2024, and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Andy Schiesl General Counsel |
Adopted 10b5-1 plan | Dec 7, 2023 | up to 35,000 | 147 days | 10-K Feb 23, 2024 |
The company's descriptionOn December 7, 2023, Andy Schiesl, the Company's General Counsel, adopted a 10b5-1 trading arrangement (a “10b5-1 Plan”). Mr. Reynal’s 10b5-1 Plan provides for the potential sale of up to 35,000 shares of the Company’s common stock from March 11, 2024 through August 5, 2024, and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. | |||||
| Vicente Reynal Chairman, President and Chief Executive Officer |
Adopted 10b5-1 plan | Nov 7, 2023 | up to 240,000 | 159 days | 10-K Feb 23, 2024 |
The company's descriptionOn November 7, 2023, Vicente Reynal, the Company's Chairman, President and Chief Executive Officer, adopted a 10b5-1 trading arrangement (a “10b5-1 Plan”). Mr. Reynal’s 10b5-1 Plan provides for the potential sale of up to 240,000 shares of the Company’s common stock, obtained from the exercise of vested stock options covered by the 10b5-1 Plan, from February 28, 2024 through August 5, 2024, and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. | |||||
| Vicente Reynal Chairman, President and Chief Executive Officer |
Adopted 10b5-1 plan | Jun 6, 2023 | up to 18,000 | 413 days | 10-Q Aug 4, 2023 |
The company's descriptionOn June 6, 2023, a trust established by Vicente Reynal, the Company's Chairman, President and Chief Executive Officer, for the benefit of himself and his spouse adopted a Rule 10b5-1 trading arrangement (the “Reynal Trust 10b5-1 Plan”). The Reynal Trust 10b5-1 Plan provides for the potential charitable gift to a donor advised wealth fund of up to 18,000 shares of the Company’s common stock from September 14, 2023 through October 31, 2023, and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. | |||||
| Vikram Kini Senior Vice President and Chief Financial Officer, |
Adopted 10b5-1 plan | Jun 6, 2023 | up to 169,153 | 195 days | 10-Q Aug 4, 2023 |
The company's descriptionOn June 6, 2023, Vikram Kini, the Company’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 trading arrangement (a “10b5-1 Plan”). Mr. Kini’s 10b5-1 Plan provides for the potential sale of up to 169,153 shares of the Company’s common stock, including shares obtained from the exercise of vested stock options covered by the 10b5-1 Plan, from September 6, 2023 through March 19, 2024, and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 5, 2023.
Form 144 notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Schiesl Andrew R Officer |
9,782 | $831,470 | Restricted Stock Vesting; Stock Option Exercise | none given | 9,782 shares from Nov 5, 2026 |
| Apr 13, 2026 | Reynal Vicente Officer, Director |
30,492 | $2,683,296 | Options Granted - 05/10/2016 | adopted May 22, 2025 | none found |
| Mar 2, 2026 | Reynal Vicente Officer, Director |
118,044 | $11,109,284 | Option Granted - 05/10/2016 | adopted May 22, 2025 | none found |
| Feb 20, 2026 | Kini Vikram Officer |
28,367 | $2,737,416 | Options Granted - 02/22/2018; Options Granted - 12/09/2016 | none given | none found |
| Feb 19, 2026 | Humphrey John Director |
4,300 | $412,369 | Restricted Stock Vesting | none given | none found |
| Feb 18, 2026 | Reynal Vicente Officer, Director |
900 | $90,000 | Option Granted - 05/10/2016 | adopted May 22, 2025 | none found |
| Feb 17, 2026 | Keene Kathleen M. Officer |
12,000 | $1,193,520 | Restricted Stock Vesting | none given | none found |
| Feb 17, 2026 | Reynal Vicente Officer, Director |
36,482 | $3,556,995 | Restricted Stock Vesting | none given | none found |
| Feb 17, 2026 | Scheske Michael J Director |
19,122 | $1,867,561 | Options Granted - 02/23/2021; Options Granted - 03/06/2020 | none given | none found |
| Feb 17, 2026 | Hepding Elizabeth Meloy Officer |
18,246 | $1,771,869 | Option Granted - 08/09/2021 | none given | none found |
| Feb 17, 2026 | Schiesl Andrew R Officer |
18,000 | $1,764,000 | Restricted Stock Vesting; Stock Option Exercise | none given | none found |
| Feb 13, 2026 | Reynal Vicente Officer, Director |
55,870 | $5,608,800 | Option Granted 05/10/2016 | adopted May 22, 2025 | none found |
| Feb 11, 2026 | Reynal Vicente Officer, Director |
440 | $44,000 | Option Granted - 05/10/2016 | adopted May 22, 2025 | none found |
| Feb 4, 2026 | Reynal Vicente Officer, Director |
90,281 | $8,840,750 | Options Granted - 05/10/2016 | adopted May 22, 2025 | none found |
| Feb 3, 2026 | Reynal Vicente Officer, Director |
9,719 | $913,630 | Option Granted - 05/10/2016 | adopted May 22, 2025 | none found |
| Jan 16, 2026 | Reynal Vicente Officer, Director |
191,000 | $16,829,997 | Option Granted 05/10/2016 | adopted May 22, 2025 | none found |
| Dec 1, 2025 | Scheske Michael J Officer |
1,477 | $119,086 | Restricted Stock Vesting | none given | none found |
From the Form 144 XML filed with the SEC, since Dec 1, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on IR in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/IR/export.csv") into a cell.